IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v18y2021i7p3671-d528244.html
   My bibliography  Save this article

A Placebo-Controlled, Pseudo-Randomized, Crossover Trial of Botanical Agents for Gulf War Illness: Reishi Mushroom ( Ganoderma lucidum ), Stinging Nettle ( Urtica dioica ), and Epimedium ( Epimedium sagittatum )

Author

Listed:
  • Jarred Younger

    (Department of Psychology, University of Alabama at Birmingham, CH 233, 1300 University Boulevard, Birmingham, AL 35233, USA)

  • Emily K. Donovan

    (Department of Psychology, Virginia Commonwealth University, White House, 806 West Franklin Street, Richmond, VA 23284, USA)

  • Kathleen S. Hodgin

    (Department of Psychology, University of Alabama at Birmingham, CH 233, 1300 University Boulevard, Birmingham, AL 35233, USA)

  • Timothy J. Ness

    (Department of Anesthesiology and Perioperative Medicine, University of Alabama at Birmingham, BMR2-208, 901 19th Street South, Birmingham, AL 35205, USA)

Abstract

This report is third in a three-part clinical trial series screening potential treatments for Gulf War Illness (GWI). The goal of the project was to rapidly identify agents to prioritize for further efficacy research. We used a placebo-controlled, pseudo-randomized, crossover design to test the effects of reishi mushroom ( Ganoderma lucidum ), stinging nettle ( Uritca dioica ), and epimedium ( Epimedium sagittatum ) in 29 men with GWI. Participants completed 30 days of symptom reports for baseline, then a botanical line consisting of 30 days of placebo, followed by 30 days each of lower-dose and higher-dose botanical. After completing a botanical line, participants were randomized to complete the protocol with another botanical, until they completed three botanical trials. GWI symptom severity, pain, and fatigue were contrasted between the four conditions (baseline, placebo, lower-dose, higher dose) using linear mixed models. GWI symptom severity was unchanged from placebo in the reishi lower-dose condition ( p = 0.603), and was higher in the higher-dose condition ( p = 0.012). Symptom severity was not decreased from placebo with lower-dose stinging nettle ( p = 0.604), but was significantly decreased with higher-dose stinging nettle ( p = 0.048). Epimedium showed no significant decreases of GWI symptoms in the lower ( p = 0.936) or higher ( p = 0.183) dose conditions. Stinging nettle, especially at higher daily dosages, may help reduce the symptoms of GWI. Epimedium does not appear to beneficially affect GWI symptom severity, and reishi may exaggerate symptoms in some GWI sufferers. These results are in a small sample and are preliminary. Further research is required to determine if stinging nettle is indeed helpful for the treatment of GWI, and what dosage is optimal. This trial was registered on ClinicalTrials.gov (NCT02909686).

Suggested Citation

  • Jarred Younger & Emily K. Donovan & Kathleen S. Hodgin & Timothy J. Ness, 2021. "A Placebo-Controlled, Pseudo-Randomized, Crossover Trial of Botanical Agents for Gulf War Illness: Reishi Mushroom ( Ganoderma lucidum ), Stinging Nettle ( Urtica dioica ), and Epimedium ( Epimedium s," IJERPH, MDPI, vol. 18(7), pages 1-13, April.
    • Handle: RePEc:gam:jijerp:v:18:y:2021:i:7:p:3671-:d:528244
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/18/7/3671/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/18/7/3671/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Anthony R. Mawson & Ashley M. Croft, 2019. "Gulf War Illness: Unifying Hypothesis for a Continuing Health Problem," IJERPH, MDPI, vol. 16(1), pages 1-16, January.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Linh M. Duong & Alice B. S. Nono Djotsa & Jacqueline Vahey & Lea Steele & Rachel Quaden & Kelly M. Harrington & Sarah T. Ahmed & Renato Polimanti & Elani Streja & John Michael Gaziano & John Concato &, 2022. "Association of Gulf War Illness with Characteristics in Deployed vs. Non-Deployed Gulf War Era Veterans in the Cooperative Studies Program 2006/Million Veteran Program 029 Cohort: A Cross-Sectional An," IJERPH, MDPI, vol. 20(1), pages 1-22, December.
    2. Chelsey Poisson & Sheri Boucher & Domenique Selby & Sylvia P. Ross & Charulata Jindal & Jimmy T. Efird & Pollie Bith-Melander, 2020. "A Pilot Study of Airborne Hazards and Other Toxic Exposures in Iraq War Veterans," IJERPH, MDPI, vol. 17(9), pages 1-15, May.
    3. Girija Kaimal & Rebekka Dieterich-Hartwell, 2020. "Grappling with Gulf War Illness: Perspectives of Gulf War Providers," IJERPH, MDPI, vol. 17(22), pages 1-11, November.
    4. Emily K. Donovan & Sophia Kekes-Szabo & Joanne C. Lin & Rebecca L. Massey & James D. Cobb & Kathleen S. Hodgin & Timothy J. Ness & Carl Hangee-Bauer & Jarred W. Younger, 2021. "A Placebo-Controlled, Pseudo-Randomized, Crossover Trial of Botanical Agents for Gulf War Illness: Curcumin ( Curcuma longa), Boswellia ( Boswellia serrata ), and French Maritime Pine Bark ( Pinus pin," IJERPH, MDPI, vol. 18(5), pages 1-15, March.
    5. Ayushi Trivedi & Dipro Bose & Kelly Moffat & Elisabeth Pearson & Dana Walsh & Devra Cohen & Jonathan Skupsky & Linda Chao & Julia Golier & Patricia Janulewicz & Kimberly Sullivan & Maxine Krengel & As, 2024. "Gulf War Illness Is Associated with Host Gut Microbiome Dysbiosis and Is Linked to Altered Species Abundance in Veterans from the BBRAIN Cohort," IJERPH, MDPI, vol. 21(8), pages 1-22, August.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:7:p:3671-:d:528244. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.